FluEvoFormer: A Structure-Guided Generative Foundation Model for Prospective Influenza Antigenic Evolution and Vaccine Strain Selection. [PDF]
Agarwal P, Yogarayan S, Sayeed MS.
europepmc +1 more source
Detection and characterization of antiviral-resistant viruses during the influenza season of 2024-25. [PDF]
Patel MC +19 more
europepmc +1 more source
Influenza virus infection during pregnancy: a review of risk factors, pathogenic mechanisms, and prevention strategies. [PDF]
Fan H +5 more
europepmc +1 more source
The roles of pre-season immunity, age, viral shedding, and community exposures in shaping influenza household transmission dynamics. [PDF]
Sauter MK +20 more
europepmc +1 more source
Exposure of dogs to influenza A and B viruses. [PDF]
Trombetta CM +15 more
europepmc +1 more source
Intranasal delivery of a COBRA-based protein vaccine adjuvanted with c-di-AMP enhances breadth of protective immune responses against seasonal influenza viruses. [PDF]
Caetano CCS +5 more
europepmc +1 more source
Efficient Production of Swine Influenza Virus Using Serum-Free Suspension MDCK Cells for Vaccine Manufacturing. [PDF]
Koo SJ, Kim YG.
europepmc +1 more source
Pulmonarom<sup>®</sup> promotes TLR-related and interferon-related antiviral responses during influenza A (H1N1 and H3N2) infection in human monocyte-derived dendritic cells. [PDF]
Solano-Gálvez SG +12 more
europepmc +1 more source
Epidemiology, temporal trends and co-infection of 13 respiratory pathogens in 32,125 children: a 3-year retrospective study. [PDF]
Zhang Y, Wang S, Huang X.
europepmc +1 more source
Nanoemulsion adjuvanted COBRA HA vaccine enhances protective antibody titers against H1N1 and H3N2 influenza viruses. [PDF]
Thomas MH, Ross TM.
europepmc +1 more source

